Levetiracetam Aristo Pharma

Levetiracetam, the active ingredient in Levetiracetam Aristo Pharma, is an anticonvulsant presented as an oral formulation for oral use. It is used to control partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Aristo Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication that modulates neuronal excitability to control seizures. - Partial seizures: reduces frequency and severity of focal onset seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes in generalized epilepsy. - Myoclonic seizures: decreases sudden muscle jerks associated with myoclonic epilepsy.

Levetiracetam may be associated with a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects: - Dizziness: feeling of light‑headedness or unsteadiness. - Fatigue: increased tiredness or lack of energy. - Headache: mild to moderate cranial pain. - Somnolence: drowsiness or sleepiness during daytime. - Irritability: mood changes or increased agitation. - Nausea: mild stomach upset.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement. - Suicidal thoughts: emergence of depressive symptoms or suicidal ideation. - Hematologic abnormalities: rare cases of neutropenia or thrombocytopenia.

When prescribing Levetiracetam, clinicians should consider several safety precautions to minimize risks. - Renal impairment: adjust dose in patients with reduced kidney function. - Psychiatric history: monitor for mood changes, depression or suicidal thoughts. - Concomitant CNS depressants: use caution as combined sedation may increase. - Pregnancy: evaluate risk‑benefit, as safety data are limited. - Elderly patients: start with lower doses and monitor for adverse effects. - Store at ambient temperature: keep below 25°C in original container, protect from moisture.

Levetiracetam can interact with other medicines, affecting its plasma levels or therapeutic effect.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam concentrations, decreasing efficacy. - Phenytoin: can lower levetiracetam levels, potentially leading to breakthrough seizures.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam exposure, requiring observation for side effects. - Sedative agents (e.g., benzodiazepines, alcohol): additive CNS depression may occur. - Other antiepileptic drugs: monitor overall seizure control and side‑effect profile.